| Antimicrobial Agent | Susceptibility Profile | Clinical Interpretation |
|---|---|---|
| Amikacin | Sensitive | <=1 |
| Amoxicillin/Clavulanic acid | Sensitive | <=2 |
| Cefepime | Sensitive | <=0.12 |
| Cefotaxime | Sensitive | <0.125 |
| Ceftazidime | Sensitive | 0.25 |
| Ceftriaxone | Sensitive | <=0.25 |
| Cefuroxime | Sensitive | <=1 |
| Ciprofloxacin | Sensitive | <=0.06 |
| Colistin | Intermediate | 0.25 |
| Ertapenem | Sensitive | <=0.12 |
| Fosfomycin | Sensitive | <=16 |
| Gentamicin | Sensitive | <=1 |
| Imipenem | Sensitive | <=0.25 |
| Levofloxacin | Sensitive | <0.125 |
| Meropenem | Sensitive | <=0.25 |
| Nitrofurantoin | Intermediate | 64 |
| Piperacillin | Sensitive | <=4 |
| Tobramycin | Sensitive | 0.25 |
| Trimethoprim/Sulfamethoxazole | Sensitive | <=20 |
| Resistant Gene Track | Detection Methodology | NCBI Genome Accession |
|---|---|---|
| oqxA | PCR |